Patents by Inventor Eric Bachelder

Eric Bachelder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
    Publication number: 20220211680
    Abstract: Provided are compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treatment and diagnosis using such compounds and compositions.
    Type: Application
    Filed: December 22, 2020
    Publication date: July 7, 2022
    Inventors: Larry SCHLESINGER, Eric Bachelder, Fred Cope, Wael N. Jarjour
  • Methods and compositions for inducing an immune response
    Patent number: 11052149
    Abstract: The present invention provides a composition comprising a) a polyacetal polymer, a polyester polymer and/or a biodegradable polymer; b) a cyclic dinucleotide; and c) an antigen and/or an antibody, as well as methods of using same.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: July 6, 2021
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Jenny P.-Y. Ting, Robert Junkins, Brandon Johnson, Kristy Ainslie, Eric Bachelder, Matthew Gallovic, Michael Collier, Ning Cheng
  • Compositions for targeting macrophages and other CD206 high expressing cells and methods of treating and diagnosis
    Patent number: 10806803
    Abstract: Provided are compounds and compositions for targeting macrophages and other CD206 high expressing cells.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: October 20, 2020
    Assignees: OHIO STATE INNOVATION FOUNDATION, CARDINAL HEALTH 414, LLC
    Inventors: Larry Schlesinger, Eric Bachelder, Frederick O. Cope
  • STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS
    Publication number: 20200197514
    Abstract: Disclosed herein are methods of using immunomodulatory sterols as vaccine adjuvants. Accordingly, certain embodiments relates to pharmaceutical compositions containing at least one antigen and at least one immunomodulatory sterol; and, methods of inducing an immunomodulatory response in a patient by administering an immunomodulatory-effective amount of at least one immunomodulatory sterol.
    Type: Application
    Filed: August 24, 2018
    Publication date: June 25, 2020
    Inventors: Abhay R. SATOSKAR, James R. FUCHS, Alan Douglas KINGHORN, Li PAN, Eric BACHELDER, Narasimham L. PARINANDI
  • METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE
    Publication number: 20190275144
    Abstract: The present invention provides a composition comprising a) a polyacetal polymer, a polyester polymer and/or a biodegradable polymer; b) a cyclic dinucleotide; and c) an antigen and/or an antibody, as well as methods of using same.
    Type: Application
    Filed: September 19, 2017
    Publication date: September 12, 2019
    Inventors: Jenny P.-Y. Ting, Robert Junkins, Brandon Johnson, Kristy Ainslie, Eric Bachelder, Matthew Gallovic, Michael Collier, Ning Cheng
  • Antileishmanial compositions and methods of use
    Patent number: 10174072
    Abstract: In one aspect, the invention relates methods and compositions for treating parasitic diseases, for example, leishmaniasis. In a further aspect, the compounds of the methods and compositions are isolated from Pentalinon andrieuxii. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: January 8, 2019
    Assignee: Ohio State Innovation Foundation
    Inventors: Abhay R. Satoskar, James F. Fuchs, Alan Douglas Kinghorn, Li Pan, Claudio M. Lezama-Davila, Eric Bachelder
  • COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA
    Publication number: 20180185334
    Abstract: Compositions and methods for inhibiting Leishmaniasis using AIs are provided. Aspects provide compositions and methods for administering AIs alone or in combination with other compounds to infected hosts.
    Type: Application
    Filed: January 10, 2018
    Publication date: July 5, 2018
    Applicant: OHIO STATE INNOVATION FOUNDATION
    Inventors: Kristy Ainslie, Eric Bachelder, Shalini Gautam, Kevin Peine, Abhay Satoskar
  • Compositions and methods for inhibiting leishmania
    Patent number: 9901569
    Abstract: Compositions and methods for inhibiting Leishmaniasis using AIs are provided. Aspects provide compositions and methods for administering AIs alone or in combination with other compounds to infected hosts.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: February 27, 2018
    Assignee: OHIO STATE INNOVATION FOUNDATION
    Inventors: Kristy Ainslie, Eric Bachelder, Shalini Gautam, Kevin Peine, Abhay Satoskar
  • ANTILEISHMANIAL COMPOSITIONS AND METHODS OF USE
    Publication number: 20170305959
    Abstract: In one aspect, the invention relates methods and compositions for treating parasitic diseases, for example, leishmaniasis. In a further aspect, the compounds of the methods and compositions are isolated from Pentalinon andrieuxii. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: January 20, 2017
    Publication date: October 26, 2017
    Inventors: Abhay R. Satoskar, James F. Fuchs, Alan Douglas Kinghorn, Li Pan, Claudio M. Lezama-Davila, Eric Bachelder
  • COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER CD206 HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS
    Publication number: 20170209584
    Abstract: Provided are compounds and compositions for targeting macrophages and other CD206 high expressing cells.
    Type: Application
    Filed: July 17, 2015
    Publication date: July 27, 2017
    Inventors: Larry SCHLESINGER, Eric BACHELDER, Fred COPE
  • COMPOUNDS AND COMPOSITIONS FOR TARGETING MACROPHAGES AND OTHER MANNOSE-BINDING C-TYPE LECTIN RECEPTOR HIGH EXPRESSING CELLS AND METHODS OF TREATING AND DIAGNOSIS USING SAME
    Publication number: 20170202969
    Abstract: Provided are compounds and compositions for targeting macrophages and other mannose-binding c-type lectin receptor high expressing cells and methods of treatment and diagnosis using such compounds and compositions.
    Type: Application
    Filed: July 17, 2015
    Publication date: July 20, 2017
    Inventors: Larry SCHLESINGER, Eric BACHELDER, Fred COPE, Wael N. JARJOUR
  • COMPOSITIONS AND METHODS FOR INHIBITING LEISHMANIA
    Publication number: 20160120844
    Abstract: Compositions and methods for inhibiting Leishmaniasis using AIs are provided. Aspects provide compositions and methods for administering AIs alone or in combination with other compounds to infected hosts.
    Type: Application
    Filed: October 27, 2015
    Publication date: May 5, 2016
    Inventors: Kristy Ainslie, Eric Bachelder, Shalini Gautam, Kevin Peine, Abhay Satoskar
  • ANTILEISHMANIAL COMPOSITIONS AND METHODS OF USE
    Publication number: 20140287030
    Abstract: In one aspect, the invention relates methods and compositions for treating parasitic diseases, for example, leishmaniasis. In a further aspect, the compounds of the methods and compositions are isolated from Pentalinon andrieuxii. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: June 9, 2014
    Publication date: September 25, 2014
    Applicant: OHIO STATE INNOVATION FOUNDATION
    Inventors: Abhay R. Satoskar, James R. Fuchs, Alan Douglas Kinghorn, Li Pan, Claudio M. Lezama-Davila, Eric Bachelder